Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Genevieve Baer
Effective February 12, 2021, the Board of Directors (the “Board”) of GreenBox POS (the “Company”) appointed Genevieve Baer as a member of the Board. The Board determined that Ms. Baer qualified as independent under the director independence standards set forth in the rules and regulations of the Securities and Exchange Commission and applicable NASDAQ listing standards. On February 16, 2021, Ms. Baer was appointed to serve as a member of the Board’s Audit, Compensation, and Nomination Committees.
On February 16, 2021, the Company and Ms. Baer entered into a Board of Directors Agreement (“Baer BOD Agreement”). Pursuant to the Baer BOD Agreement, Ms. Baer will receive cash compensation in the amount of $2,500 per month as well as equity compensation in the form of shares of the Company’s common stock in an amount equal to $2,500 per month. Additionally, from time to time, Ms. Baer may receive awards pursuant to the Company’s Equity Incentive Plan.
There is no arrangement or understanding between Ms. Baer and any other persons pursuant to which Ms. Baer was selected as a director, and there are no related party transactions involving Ms. Baer that are reportable under Item 404(a) of Regulation S-K.
Below is a description of Ms. Baer’s professional work experience.
Genevieve Baer, 43, Director
Ms. Baer has been chief executive officer of JKH Consulting since 2009. JKH Consulting is a real estate finance consulting firm that has advised on transactions with a collective value of over $10 billion. Prior to her work with JKH Consulting, Ms. Baer worked at Magnet Industrial Bank for 6 years at the end of which tenure she was a Senior Vice President. Ms. Baer also worked at US Bancorp Piper Jaffray for 9 years as a Vice President working on equity and debt real estate financings. Ms. Baer earned a B.S. in chemistry from the University of Utah.
William J. Caragol
Effective February 12, 2021, the Board appointed William J. Caragol as a member of the Board. The Board determined that Mr. Caragol qualified as independent under the director independence standards set forth in the rules and regulations of the Securities and Exchange Commission and applicable NASDAQ listing standards. In addition, the Board has determined that Mr. Caragol qualifies as an “audit committee financial expert,” as such term is defined in Item 407(d)(5) of Regulation S-K. On February 16, 2021, Mr. Caragol was appointed to serve as a member and chairman of the Board’s Audit, Compensation, and Nomination Committees.
On February 16, 2021, the Company and Mr. Caragol entered into a Board of Directors Agreement (“Caragol BOD Agreement”). Pursuant to the Caragol BOD Agreement, Mr. Caragol will receive cash compensation in the amount of $5,000 per month as well as equity compensation in the form of shares of the Company’s common stock in an amount equal to $5,000 per month. Additionally, from time to time, Mr. Caragol may receive awards pursuant to the Company’s Equity Incentive Plan.
There is no arrangement or understanding between Mr. Caragol and any other persons pursuant to which Mr. Caragol was selected as a director, and there are no related party transactions involving Mr. Caragol that are reportable under Item 404(a) of Regulation S-K.
Below is a description of Mr. Caragol’s professional work experience.
William J. Caragol, 53, Director
Mr. Caragol has, since April 2020, been Executive Vice President and Chief Financial Officer of Hawaiian Springs LLC, a natural artesian bottled water company. From 2018 to the present, Mr. Caragol has also been Managing Director of Quidem LLC, a corporate advisory firm. Since 2015, Mr. Caragol has been Chairman of the Board of Thermomedics, Inc., a medical diagnostic equipment company. From 2012 to 2018, Mr. Caragol was Chairman and CEO of PositiveID, a holding company that was publicly traded that had a portfolio of products in the fields of bio detection systems, molecular diagnostics, and diabetes management products. Mr. Caragol earned a B.S. in business administration and accounting from Washington & Lee University.
Ezra Laniado
Effective February 12, 2021, the Board appointed Ezra Laniado as a member of the Board. The Board determined that Mr. Laniado qualified as independent under the director independence standards set forth in the rules and regulations of the Securities and Exchange Commission and applicable NASDAQ listing standards. On February 16, 2021, Mr. Laniado was appointed to serve as a member of the Board’s Audit, Compensation, and Nomination Committees.
On February 16, 2021, the Company and Mr. Laniado entered into a Board of Directors Agreement (“Laniado BOD Agreement”). Pursuant to the Laniado BOD Agreement, Mr. Laniado will receive cash compensation in the amount of $2,500 per month as well as equity compensation in the form of shares of the Company’s common stock in an amount equal to $2,500 per month. Additionally, from time to time, Mr. Laniado may receive awards pursuant to the Company’s Equity Incentive Plan.
The terms of each of the Baer, Caragol, and Laniado BOD Agreements are substantially the same (other than the compensation of Mr. Caragol). The description of the Baer, Caragol, and Laniado BOD Agreements in this Current Report on Form 8-K is not complete and is qualified in its entirety by reference to the full text of the form of BOD Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The Company and each of Ms. Baer and Messrs. Caragol and Laniado agreed to execute an indemnification agreement in favor of the Board member substantially in the form of the agreement attached to each BOD Agreement as Exhibit A (the “Indemnification Agreement”). In addition, so long as the Company’s indemnification obligations exist under the Indemnification Agreement, the Company shall provide the Board member with directors’ and officers’ liability insurance coverage in the amounts specified in the Indemnification Agreement.
There is no arrangement or understanding between Mr. Laniado and any other persons pursuant to which Mr. Laniado was selected as a director, and there are no related party transactions involving Mr. Laniado that are reportable under Item 404(a) of Regulation S-K.
Below is a description of Mr. Laniado’s professional work experience.
Ezra Laniado, 37, Director
Mr. Laniado has, since 2018, been Executive Director of the San Diego chapter of Friends of Israel Defence Forces and, since 2017, been Regional Director of the San Diego chapter of the Israeli-American Council, two American charitable organizations providing support and funds for Israel and the Israeli community in America. In such capacity, Mr. Laniado has raised over $5 million in donations and managed over 30 volunteers. From 2014 to 2017, Mr. Laniado was Co-Founder and Business Director of Shonglulu Group, a fashion brand. As Business Director, Mr. Laniado raised capital, coordinated the company’s marketing strategy, and implemented its business plan. Prior to 2014, Mr. Laniado was an attorney in Israel for 4 years. Mr. Laniado received a B.A. and an L.L.B. from the Interdisciplinary Center Herzliya.